Antarctic sympagic meiofauna in winter: Comparing diversity, abundance and biomass between perennially and seasonally ice-covered regions

This study of Antarctic sympagic meiofauna in pack ice during late winter compares communities between the perennially ice-covered western Weddell Sea and the seasonally ice-covered southern Indian Ocean. Sympagic meiofauna (proto- and metazoans >20 μm) and eggs >20 μm were studied in terms of diversity, abundance and carbon biomass, and with respect to vertical distribution. Metazoan meiofauna had significantly higher abundance and biomass in the western Weddell Sea (medians: 31.1×103 m−2 and 6.53mg m−2, respectively) than in the southern Indian Ocean (medians: 1.0×10 103 m−2and 0.06 mg m−2, respectively). Metazoan diversity was also significantly higher in the western Weddell Sea. Furthermore, the two regions differed significantly in terms of meiofauna community composition, as revealed through multivariate analyses. The overall diversity of sympagic meiofauna was high, and integrated abundance and biomass of total meiofauna were also high in both regions (0.6–178.6×103 m−2 and 0.02–89.70mg m−2, respectively), mostly exceeding values reported earlier from the western Weddell Sea in winter. We attribute the differences in meiofauna communities between the two regions to the older first-year ice and multi-year ice that is present in the western Weddell Sea, but not in the southern Indian Ocean. Our study indicates the significance of perennially ice-covered regions for the establishment of diverse and abundant meiofauna communities. Furthermore, it highlights the potential importance of sympagic meiofauna for the organic matter pool and trophic interactions in sea ice

Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk

Previous research has shown that polygenic risk scores (PRSs) can be used to stratify women according to their risk of developing primary invasive breast cancer. This study aimed to evaluate the association between a recently validated PRS of 313 germline variants (PRS313) and contralateral breast cancer (CBC) risk. We included 56,068 women of European ancestry diagnosed with first invasive breast cancer from 1990 onward with follow-up from the Breast Cancer Association Consortium. Metachronous CBC risk (N = 1,027) according to the distribution of PRS313 was quantified using Cox regression analyses. We assessed PRS313 interaction with age at first diagnosis, family history, morphology, ER status, PR status, and HER2 status, and (neo)adjuvant therapy. In studies of Asian women, with limited follow-up, CBC risk associated with PRS313 was assessed using logistic regression for 340 women with CBC compared with 12,133 women with unilateral breast cancer. Higher PRS313 was associated with increased CBC risk: hazard ratio per standard deviation (SD) = 1.25 (95%CI = 1.18-1.33) for Europeans, and an OR per SD = 1.15 (95%CI = 1.02-1.29) for Asians. The absolute lifetime risks of CBC, accounting for death as competing risk, were 12.4% for European women at the 10th percentile and 20.5% at the 90th percentile of PRS313. We found no evidence of confounding by or interaction with individual characteristics, characteristics of the primary tumor, or treatment. The C-index for the PRS313 alone was 0.563 (95%CI = 0.547-0.586). In conclusion, PRS313 is an independent factor associated with CBC risk and can be incorporated into CBC risk prediction models to help improve stratification and optimize surveillance and treatment strategies.Peer reviewe

Social robots in the Swiss healthcare system : possible applications, chances and risks from the perspective of potential user groups

Erworben im Rahmen der Schweizer Nationallizenzen (http://www.nationallizenzen.ch)Dieser Beitrag der Zeitschrift Gruppe. Interaktion. Organisation. (GIO) berichtet und vertieft die Ergebnisse eines interprofessionellen Projektes im Auftrag der TA-SWISS (Stiftung für Technologiefolgen-Abschätzung). In dem Projekt wurde u. a. untersucht, wie soziale Roboter aus der Sicht von Gesundheitsfachpersonen und von Bewohnerinnen und Bewohnern eines Alterszentrums zukünftig in der Schweiz eingesetzt werden können und welche Chancen und Risiken sie bei diesem Einsatz sehen. Hintergrund dieser Fragestellung war, dass soziale Roboter zunehmend im Gesundheitsbereich eingesetzt werden, die Perspektiven der potenziellen Anwenderinnen und Anwender jedoch nur wenig bekannt sind. Daher wurde mit einem explorativen Studiendesign im August 2020 ein Workshop („Round Table Gesundheit“) mit 26 Teilnehmenden durchgeführt, der Roboterszenarien, vier Fokusgruppeninterviews und eine Nachbefragung beinhaltete. Es zeigte sich in der vertieften Analyse, dass sich die von den Teilnehmenden genannten Einsatzmöglichkeiten von sozialen Robotern einerseits in zwei Anwendergruppen („Patientinnen/Patienten“ und „Gesundheitsfachpersonen“) und andererseits in zwei Rollen des sozialen Roboters (persönlich zugeordnet – „persönlicher Buddy/Assistent“ und nicht persönlich zugeordnet – „hilfreicher Kollege“) einteilen liessen. Die Chancen und Risiken sozialer Roboter liessen sich in die drei Spannungsfelder „Selbstbestimmung vs. soziale Isolation“, „Entlastung vs. Belastung & Abhängigkeit“ und „Sicherheit vs. Gefahren“ kategorisieren. Von potenziellen Anwenderinnen und Anwendern werden somit vielfältige Einsatzmöglichkeiten und Chancen für soziale Roboter im Gesundheitsbereich gesehen. Gleichzeitig gilt es auch die Risiken zu berücksichtigen und zu minimieren, damit soziale Roboter zukünftig erfolgreich in der Praxis eingesetzt werden können

Cognitive change is more positively associated with an active lifestyle than with training interventions in older adults at risk of dementia: a controlled interventional clinical trial

Background: While observational studies show that an active lifestyle including cognitive, physical, and social activities is associated with a reduced risk of cognitive decline and dementia, experimental evidence from corresponding training interventions is more inconsistent with less pronounced effects. The aim of this study was to evaluate and compare training- and lifestyle-related changes in cognition. This is the first study investigating these associations within the same time period and sample. Methods: Fifty-four older adults at risk of dementia were assigned to 10 weeks of physical training, cognitive training, or a matched wait-list control condition. Lifestyle was operationalized as the variety of self-reported cognitive, physical, and social activities before study participation. Cognitive performance was assessed with an extensive test battery prior to and after the intervention period as well as at a 3-month follow-up. Composite cognition measures were obtained by means of a principal component analysis. Training- and lifestyle-related changes in cognition were analyzed using linear mixed effects models. The strength of their association was compared with paired t-tests. Results: Neither training intervention improved global cognition in comparison to the control group (p = .08). In contrast, self-reported lifestyle was positively associated with benefits in global cognition (p < .001) and specifically in memory (p < .001). Moreover, the association of an active lifestyle with cognitive change was significantly stronger than the benefits of the training interventions with respect to global cognition (ps < .001) and memory (ps < .001). Conclusions: The associations of an active lifestyle with cognitive change over time in a dementia risk group were stronger than the effects of short-term, specific training interventions. An active lifestyle may differ from training interventions in dosage and variety of activities as well as intrinsic motivation and enjoyment. These factors might be crucial for designing novel interventions, which are more efficient than currently available training interventions

The influence of adjuvant systemic regimens on contralateral breast cancer risk and receptor subtype

Background: An increasing number of breast cancer (BC) survivors are at risk of developing contralateral breast cancer (CBC). We aimed to investigate the influence of various adjuvant systemic regimens on, subtype-specific, risk of CBC. Methods: This population-based cohort study included female patients diagnosed with first invasive BC between 2003 and 2010; follow-up was complete until 2016. Clinico-pathological data were obtained from the Netherlands Cancer Registry and additional data on receptor status through linkage with PALGA: the Dutch Pathology Registry. Cumulative incidences (death and distant metastases as competing risk) and hazard ratios (HRs) were estimated for all invasive metachronous CBC and CBC subtypes. Results: Of 83 144 BC patients, 2816 developed a CBC; the 10-year cumulative incidence was 3.8% (95% confidence interval [CI]=3.7% to 4.0%). Overall, adjuvant chemotherapy (HR=0.70, 95% CI=0.62 to 0.80), endocrine therapy (HR=0.46, 95% CI=0.41 to 0.52), and trastuzumab with chemotherapy (HR=0.57, 95% CI=0.45 to 0.73) were strongly associated with a reduced CBC risk. Specifically, taxane-containing chemotherapy (HR=0.48, 95% CI=0.36 to 0.62) and aromatase inhibitors (HR=0.32, 95% CI=0.23 to 0.44) were associated with a large CBC risk reduction. More detailed analyses showed that endocrine therapy statistically significantly decreased the risk of estrogen receptor (ER)-positive CBC (HR=0.41, 95% CI=0.36 to 0.47) but not ER-negative CBC (HR=1.32, 95% CI=0.90 to 1.93) compared with no endocrine therapy. Patients receiving chemotherapy for ER-negative first BC had a higher risk of ER-negative CBC from 5years of follow-up (HR=2.84, 95% CI=1.62 to 4.99) compared with patients not receiving chemotherapy for ER-negative first BC. Conclusion: Endocrine therapy, chemotherapy, as well as trastuzumab with chemotherapy reduce CBC risk. However, each adjuvant therapy regimen had a different impact on the CBC subtype distribution. Taxane-containing chemotherapy and aromatase inhibitors were associated with the largest CBC risk reduction

Soziale Roboter, Empathie und Emotionen : eine Untersuchung aus interdisziplinärer Perspektive

Bericht: «Soziale Roboter, Empathie und Emotionen»Robots, empathy, emotions, technology assessmen

A systematic review of studies measuring and reporting hearing aid usage in older adults since 1999: a descriptive summary of measurement tools

Objective: A systematic review was conducted to identify and quality assess how studies published since 1999 have measured and reported the usage of hearing aids in older adults. The relationship between usage and other dimensions of hearing aid outcome, age and hearing loss are summarised. Data sources: Articles were identified through systematic searches in PubMed/MEDLINE, The University of Nottingham Online Catalogue, Web of Science and through reference checking. Study eligibility criteria: (1) participants aged fifty years or over with sensori-neural hearing loss, (2) provision of an air conduction hearing aid, (3) inclusion of hearing aid usage measure(s) and (4) published between 1999 and 2011. Results: Of the initial 1933 papers obtained from the searches, a total of 64 were found eligible for review and were quality assessed on six dimensions: study design, choice of outcome instruments, level of reporting (usage, age, and audiometry) and cross validation of usage measures. Five papers were rated as being of high quality (scoring 10–12), 35 papers were rated as being of moderate quality (scoring 7–9), 22 as low quality (scoring 4–6) and two as very low quality (scoring 0–2). Fifteen different methods were identified for assessing the usage of hearing aids. Conclusions: Generally, the usage data reviewed was not well specified. There was a lack of consistency and robustness in the way that usage of hearing aids was assessed and categorised. There is a need for more standardised level of reporting of hearing aid usage data to further understand the relationship between usage and hearing aid outcomes

Pathogen effector recognition-dependent association of NRG1 with EDS1 and SAG101 in TNL receptor immunity

Plants utilise intracellular nucleotide-binding, leucine-rich repeat (NLR) immune receptors to detect pathogen effectors and activate local and systemic defence. NRG1 and ADR1 “helper” NLRs (RNLs) cooperate with enhanced disease susceptibility 1 (EDS1), senescence-associated gene 101 (SAG101) and phytoalexin-deficient 4 (PAD4) lipase-like proteins to mediate signalling from TIR domain NLR receptors (TNLs). The mechanism of RNL/EDS1 family protein cooperation is not understood. Here, we present genetic and molecular evidence for exclusive EDS1/SAG101/NRG1 and EDS1/PAD4/ADR1 co-functions in TNL immunity. Using immunoprecipitation and mass spectrometry, we show effector recognition-dependent interaction of NRG1 with EDS1 and SAG101, but not PAD4. An EDS1-SAG101 complex interacts with NRG1, and EDS1-PAD4 with ADR1, in an immune-activated state. NRG1 requires an intact nucleotide-binding P-loop motif, and EDS1 a functional EP domain and its partner SAG101, for induced association and immunity. Thus, two distinct modules (NRG1/EDS1/SAG101 and ADR1/EDS1/PAD4) mediate TNL receptor defence signalling

1000 Genomes-based meta-analysis identifies 10 novel loci for kidney function

HapMap imputed genome-wide association studies (GWAS) have revealed &gt;50 loci at which common variants with minor allele frequency &gt;5% are associated with kidney function. GWAS using more complete reference sets for imputation, such as those from The 1000 Genomes project, promise to identify novel loci that have been missed by previous efforts. To investigate the value of such a more complete variant catalog, we conducted a GWAS meta-analysis of kidney function based on the estimated glomerular filtration rate (eGFR) in 110,517 European ancestry participants using 1000 Genomes imputed data. We identified 10 novel loci with p-value &lt; 5 × 10(-8) previously missed by HapMap-based GWAS. Six of these loci (HOXD8, ARL15, PIK3R1, EYA4, ASTN2, and EPB41L3) are tagged by common SNPs unique to the 1000 Genomes reference panel. Using pathway analysis, we identified 39 significant (FDR &lt; 0.05) genes and 127 significantly (FDR &lt; 0.05) enriched gene sets, which were missed by our previous analyses. Among those, the 10 identified novel genes are part of pathways of kidney development, carbohydrate metabolism, cardiac septum development and glucose metabolism. These results highlight the utility of re-imputing from denser reference panels, until whole-genome sequencing becomes feasible in large samples